Designing Paclitaxel Drug Delivery Systems Aimed at Improved  Patient Outcomes: Current Status and Challenges

<table>Inhibition of HeLa cell proliferation by paclitaxel oleate in lipid emulsions. Incubation times were 24 (●), 48 (▿), 72 (●), and 96 h (<i>◊</i>).The effect of paclitaxel in Cremophor EL/ethanol at 48 h (▴) is shown as comparison. Control growth = 100. Values are mean ± S.D., <svg height="10.8125" id="M2" style="vertical-align:-0.10033pt" version="1.1" viewbox="0 0 35.099998 10.8125" width="35.099998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.8125)">
<g transform="translate(72,-63.35)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">4</tspan>
</text>
</g>
</g>
</svg> (reproduced with permission from Lundberg et al., [<a href="/journals/isrn/2012/623139/#B64">64</a>]).</table>

International Scholarly Research Notices

fig14

Figure 14

Figure 14: Designing Paclitaxel Drug Delivery Systems Aimed at Improved  Patient Outcomes: Current Status and Challenges 